Can i switch from ajovy to emgality?

How do doctors decide when to switch migraine treatments like Ajovy and Emgality?

Doctors usually switch patients from Ajovy to Emgality when the first drug fails to cut migraine days enough or produces side effects that keep patients from sticking with it. Both drugs belong to the same class of CGRP monoclonal antibodies and work by blocking calcitonin gene-related peptide. They share similar efficacy and safety profiles, so a switch is often made to try a different formulation or dosing schedule rather than a completely new mechanism.

Can patients actually change from Ajovy to Emgality safely?

Patients can switch from Ajovy to Emgality under medical supervision. No washout period is required between the two drugs. After stopping Ajovy, patients can usually start Emgality right away or at the time of the next scheduled injection date. Physicians often align the new injection with the timing of the old one to avoid gaps in coverage.

How does Ajovy differ from Emgality in dosing and administration?

Ajovy comes in 225 mg prefilled syringes or pens. Patients can choose 225 mg once a month or 675 mg every three months. Emgality uses 120 mg prefilled pens or syringes. Patients load with 240 mg at month one, then maintain 120 mg monthly. The monthly schedule for both kann be aligned when switching.

What should patients watch for during a switch?

Patients report fewer injection-site reactions with one brand over another. Some people find the pen easier to use or feel better after the switch. No increased risk of rebound headaches or adverse events has been shown when moving directly from one to the other.